No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
57 |
4. Check minimum number of eventsNone |
57 |
5. Include endpointsNone |
57 |
6. Filter based on genotype QC (FinnGen only) |
57 |
Control definitions (FinnGen only)
- Control exclude
- G6_MYONEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G72
- Name in latin
- Myopathia inflammatoria non alibi classificata
Similar endpoints
↥List of similar endpoints to
Inflammatory myopathy
based on the number of shared cases.
Similar with more cases:
- Diseases of the myoneural junction and muscle
- Neurological diseases
- Neurological diseases, wide definition
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 383 | 177 | 205 |
| Only index persons | 356 | 166 | 190 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 72.29 | 72.78 | 71.86 |
| Only index persons | 72.51 | 73.14 | 71.96 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 57 | 28 | 29 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 74.97 | 74.25 | 75.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 57
- Matched controls
- 570
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G724, ,
ICD-10 Finland
Inflammatory myopathy, not elsewhere classified
+∞
78.9
56
*
A98, ,
ICD-O-3
+∞
72.0
53
*
J01DB01, ,
ATC
cefalexin; oral
+∞
62.4
48
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
60.7
47
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
58.9
46
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
58.9
46
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
49.3
40
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
49.3
40
*
J01DA01, ,
ATC
[U] cefalexin
+∞
41.9
35
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
41.9
35
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
39.1
33
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
39.1
33
*
SAA01, ,
ICD-O-3
+∞
39.1
33
*
GD1AA, ,
ICD-O-3
+∞
39.1
33
*
WX110, ,
ICD-O-3
+∞
37.7
32
*
SPAT1223, ,
ICD-O-3
+∞
36.4
31
*
SPAT1263, ,
ICD-O-3
+∞
36.4
31
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
36.4
31
*
L28, ,
ICD-O-3
+∞
35.0
30
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
35.0
30
*
SPAT1256, ,
ICD-O-3
+∞
35.0
30
*
I10, ,
ICD-O-3
+∞
35.0
30
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
32.4
28
*
AA1AD, ,
ICD-O-3
+∞
32.4
28
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
32.4
28
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
32.4
28
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
32.4
28
*
ZXD05, ,
ICD-O-3
+∞
31.1
27
*
SAA02, ,
ICD-O-3
+∞
31.1
27
*
S18, ,
ICD-O-3
+∞
31.1
27
*
UJD10, ,
ICD-O-3
+∞
31.1
27
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
31.1
27
*
SPAT1249, ,
ICD-O-3
+∞
29.8
26
*
C10AA01, ,
ATC
simvastatin; oral
+∞
28.5
25
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
28.5
25
*
M03BX02, ,
ATC
tizanidine; oral
+∞
28.5
25
*
CJE20, ,
ICD-O-3
+∞
28.5
25
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
28.5
25
*
GD1QA, ,
ICD-O-3
+∞
28.5
25
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
27.3
24
*
C08CA01, ,
ATC
amlodipine; oral
+∞
27.3
24
*
SFA20, ,
ICD-O-3
+∞
27.3
24
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
27.3
24
*
M608, ,
ICD-10 Finland
Other myositis
+∞
27.3
24
*
R13, ,
ICD-10 Finland
Dysphagia
+∞
27.3
24
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
26.0
23
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
26.0
23
*
EB1AA, ,
ICD-O-3
+∞
26.0
23
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
26.0
23
*
SPAT1230, ,
ICD-O-3
+∞
26.0
23
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
26.0
23
*
Z024, ,
ICD-O-3
+∞
26.0
23
*
SFA10, ,
ICD-O-3
+∞
26.0
23
*
C03CA01, ,
ATC
furosemide; systemic
+∞
24.8
22
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
24.8
22
*
SPAT1250, ,
ICD-O-3
+∞
24.8
22
*
KMAK, ,
ICD-O-3
+∞
24.8
22
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
24.8
22
*
R4110, ,
ICD-O-3
+∞
23.6
21
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
23.6
21
*
SPAT1216, ,
ICD-O-3
+∞
23.6
21
*
WX408, ,
ICD-O-3
+∞
22.3
20
*
FM1EE, ,
ICD-O-3
+∞
22.3
20
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
22.3
20
*
SPAT1153, ,
ICD-O-3
+∞
22.3
20
*
N05CF01, ,
ATC
zopiclone; oral
+∞
21.1
19
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
21.1
19
*
WZC00, ,
ICD-O-3
+∞
21.1
19
*
SPAT1310, ,
ICD-O-3
+∞
21.1
19
*
K021, ,
ICD-O-3
+∞
21.1
19
*
SPAT1229, ,
ICD-O-3
+∞
21.1
19
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
21.1
19
*
J069, ,
ICD-O-3
+∞
21.1
19
*
M02AA07, ,
ATC
piroxicam; topical
+∞
21.1
19
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
21.1
19
*
SPAT1253, ,
ICD-O-3
+∞
21.1
19
*
A10BA02, ,
ATC
metformin; oral
+∞
21.1
19
*
SAA03, ,
ICD-O-3
+∞
21.1
19
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
19.9
18
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
19.9
18
*
SPAT1262, ,
ICD-O-3
+∞
19.9
18
*
D07AC01, ,
ATC
betamethasone; topical
+∞
19.9
18
*
ZXE10, ,
ICD-O-3
+∞
19.9
18
*
WX290, ,
ICD-O-3
+∞
19.9
18
*
I48, ,
ICD-10 Finland
Atrial fibrillation and flutter
+∞
19.9
18
*
G729, ,
ICD-10 Finland
Myopathy, unspecified
+∞
19.9
18
*
SPAT1222, ,
ICD-O-3
+∞
19.9
18
*
SPAT1148, ,
ICD-O-3
+∞
19.9
18
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
19.9
18
*
D07AC13, ,
ATC
mometasone; topical
+∞
18.8
17
*
GD1UA, ,
ICD-O-3
+∞
18.8
17
*
FN1AC, ,
ICD-O-3
+∞
18.8
17
*
M796, ,
ICD-O-3
+∞
18.8
17
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
18.8
17
*
M608, ,
ICD-O-3
+∞
18.8
17
*
E0000UV, ,
ATC
+∞
18.8
17
*
EBA00, ,
ICD-O-3
+∞
18.8
17
*
SPAT1325, ,
ICD-O-3
+∞
18.8
17
*
SPAT1053, ,
ICD-O-3
+∞
18.8
17
*
M01AX17, ,
ATC
nimesulide; oral
+∞
17.6
16
*
L17, ,
ICD-O-3
+∞
17.6
16
*
SPAT1254, ,
ICD-O-3
+∞
17.6
16
*
EB1SA, ,
ICD-O-3
+∞
17.6
16
*
WX320, ,
ICD-O-3
+∞
17.6
16
*
EB1HA, ,
ICD-O-3
+∞
17.6
16
*
SFA30, ,
ICD-O-3
+∞
17.6
16
*
UJF32, ,
ICD-O-3
+∞
17.6
16
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
17.6
16
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
17.6
16
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
17.6
16
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
17.6
16
*
C09AA05, ,
ATC
ramipril; oral
+∞
17.6
16
*
R06AE07, ,
ATC
cetirizine; oral
+∞
17.6
16
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
17.6
16
*
ZXE00, ,
ICD-O-3
+∞
17.6
16
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
17.6
16
*
R05, ,
ICD-O-3
+∞
17.6
16
*
Z012, ,
ICD-O-3
+∞
17.6
16
*
A28, ,
ICD-O-3
+∞
17.6
16
*
290, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
17.6
16
*
M545, ,
ICD-O-3
+∞
17.6
16
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
17.6
16
*
R01AD09, ,
ATC
mometasone; nasal
+∞
16.4
15
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
16.4
15
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
16.4
15
*
JC2KB, ,
ICD-O-3
+∞
16.4
15
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
16.4
15
*
I509, ,
ICD-10 Finland
Heart failure, unspecified
+∞
16.4
15
*
WX002, ,
ICD-O-3
+∞
16.4
15
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
16.4
15
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
16.4
15
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
16.4
15
*
WYA05, ,
ICD-O-3
+∞
16.4
15
*
M609, ,
ICD-10 Finland
Myositis, unspecified
+∞
16.4
15
*
SPAT1301, ,
ICD-O-3
+∞
16.4
15
*
SPAT1033, ,
ICD-O-3
+∞
15.3
14
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
15.3
14
*
SDA03, ,
ICD-O-3
+∞
15.3
14
*
C09CA01, ,
ATC
losartan; oral
+∞
15.3
14
*
D82, ,
ICD-O-3
+∞
15.3
14
*
B01AF01, ,
ATC
rivaroxaban; oral
+∞
15.3
14
*
N02AE01, ,
ATC
buprenorphine; parenteral, sublingual, transdermal
+∞
15.3
14
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
15.3
14
*
G728, ,
ICD-10 Finland
Other specified myopathies
+∞
15.3
14
*
SPAT1312, ,
ICD-O-3
+∞
15.3
14
*
S29, ,
ICD-O-3
+∞
15.3
14
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
15.3
14
*
Z3226, ,
ICD-O-3
+∞
15.3
14
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
15.3
14
*
WW200, ,
ICD-O-3
+∞
14.1
13
*
H258, ,
ICD-10 Finland
Other senile cataract
+∞
14.1
13
*
351, ,
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
14.1
13
*
WZB00, ,
ICD-O-3
+∞
14.1
13
*
R5110, ,
ICD-O-3
+∞
14.1
13
*
207, ,
Kela drug reimbursment
Chronic arrhythmias
+∞
14.1
13
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
14.1
13
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
14.1
13
*
Z3231, ,
ICD-O-3
+∞
14.1
13
*
65000, ,
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
+∞
14.1
13
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
14.1
13
*
SPAT1137, ,
ICD-O-3
+∞
14.1
13
*
ZXD10, ,
ICD-O-3
+∞
14.1
13
*
L15, ,
ICD-O-3
+∞
14.1
13
*
N03AX16, ,
ATC
[U] pregabalin
+∞
14.1
13
*
M05BA04, ,
ATC
alendronic acid; oral
+∞
13.0
12
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
13.0
12
*
SPAT1306, ,
ICD-O-3
+∞
13.0
12
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
13.0
12
*
SPAT1215, ,
ICD-O-3
+∞
13.0
12
*
Z871, ,
ICD-O-3
+∞
13.0
12
*
C09AA02, ,
ATC
enalapril; systemic
+∞
13.0
12
*
N05BA04, ,
ATC
oxazepam; oral
+∞
13.0
12
*
WX402, ,
ICD-O-3
+∞
13.0
12
*
R298, ,
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
+∞
13.0
12
*
NXL00, ,
ICD-O-3
+∞
13.0
12
*
GD1PA, ,
ICD-O-3
+∞
13.0
12
*
WZC30, ,
ICD-O-3
+∞
13.0
12
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
13.0
12
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
13.0
12
*
A06AD11, ,
ATC
lactulose; oral
+∞
13.0
12
*
I48, ,
ICD-O-3
+∞
13.0
12
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
13.0
12
*
C10AX09, ,
ATC
ezetimibe; oral
+∞
13.0
12
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
13.0
12
*
J690, ,
ICD-10 Finland
Pneumonitis due to food and vomit
+∞
11.9
11
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
11.9
11
*
K85, ,
ICD-O-3
+∞
11.9
11
*
C01DA02, ,
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
+∞
11.9
11
*
Z712, ,
ICD-10 Finland
Person consulting for explanation of investigation findings
+∞
11.9
11
*
SCA01, ,
ICD-O-3
+∞
11.9
11
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
11.9
11
*
R74, ,
ICD-O-3
+∞
11.9
11
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
11.9
11
*
SDA02, ,
ICD-O-3
+∞
11.9
11
*
W00, ,
ICD-10 Finland
Fall on same level involving ice and snow
+∞
11.9
11
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
11.9
11
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
11.9
11
*
-1, ,
ICD-O-3
+∞
11.9
11
*
SPAT1097, ,
ICD-O-3
+∞
11.9
11
*
SPAT1156, ,
ICD-O-3
+∞
11.9
11
*
WX100, ,
ICD-O-3
+∞
11.9
11
*
ZXA10, ,
ICD-O-3
+∞
11.9
11
*
SPAT1260, ,
ICD-O-3
+∞
11.9
11
*
G724, ,
ICD-O-3
+∞
11.9
11
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
11.9
11
*
SPAT1220, ,
ICD-O-3
+∞
10.7
10
*
K86, ,
ICD-O-3
+∞
10.7
10
*
JN3AE, ,
ICD-O-3
+∞
10.7
10
*
N18, ,
ICD-O-3
+∞
10.7
10
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
10.7
10
*
T90, ,
ICD-O-3
+∞
10.7
10
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
10.7
10
*
M171, ,
ICD-10 Finland
Other primary gonarthrosis
+∞
10.7
10
*
N05AH04, ,
ATC
quetiapine; oral
+∞
10.7
10
*
I251, ,
ICD-10 Finland
Atherosclerotic heart disease
+∞
10.7
10
*
JDB10, ,
ICD-O-3
+∞
10.7
10
*
L19, ,
ICD-O-3
+∞
10.7
10
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
10.7
10
*
L12, ,
ICD-O-3
+∞
10.7
10
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
10.7
10
*
SPAT1255, ,
ICD-O-3
+∞
10.7
10
*
L03, ,
ICD-O-3
+∞
10.7
10
*
ZXA05, ,
ICD-O-3
+∞
10.7
10
*
A03, ,
ICD-O-3
+∞
10.7
10
*
WX404, ,
ICD-O-3
+∞
10.7
10
*
A04, ,
ICD-O-3
+∞
10.7
10
*
SPAT1304, ,
ICD-O-3
+∞
10.7
10
*
M255, ,
ICD-O-3
+∞
10.7
10
*
L08, ,
ICD-O-3
+∞
10.7
10
*
WZA90, ,
ICD-O-3
+∞
10.7
10
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
10.7
10
*
H02AB07, ,
ATC
prednisone; oral
+∞
10.7
10
*
SPAT1234, ,
ICD-O-3
+∞
10.7
10
*
A29, ,
ICD-O-3
+∞
10.7
10
*
TQX10, ,
ICD-O-3
+∞
10.7
10
*
P20, ,
ICD-O-3
+∞
10.7
10
*
SFA40, ,
ICD-O-3
+∞
9.6
9
*
504, ,
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
+∞
9.6
9
*
L04AX01, ,
ATC
azathioprine; systemic
+∞
9.6
9
*
J189, ,
ICD-O-3
+∞
9.6
9
*
R060, ,
ICD-O-3
+∞
9.6
9
*
JCA55, ,
ICD-O-3
+∞
9.6
9
*
KC1EE, ,
ICD-O-3
+∞
9.6
9
*
R06AX27, ,
ATC
desloratadine; oral
+∞
9.6
9
*
N06AB04, ,
ATC
citalopram; systemic
+∞
9.6
9
*
FM1AE, ,
ICD-O-3
+∞
9.6
9
*
SPAT1149, ,
ICD-O-3
+∞
9.6
9
*
J02AC02, ,
ATC
itraconazole; systemic
+∞
9.6
9
*
N28, ,
ICD-O-3
+∞
9.6
9
*
N05CF02, ,
ATC
zolpidem; oral
+∞
9.6
9
*
NG1AA, ,
ICD-O-3
+∞
9.6
9
*
N06AB10, ,
ATC
escitalopram; oral
+∞
9.6
9
*
Z033, ,
ICD-10 Finland
Observation for suspected nervous system disorder
+∞
9.6
9
*
A97, ,
ICD-O-3
+∞
9.6
9
*
B01AA03, ,
ATC
warfarin; systemic
+∞
9.6
9
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
9.6
9
*
I2149, ,
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
+∞
9.6
9
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
9.6
9
*
G04BD12, ,
ATC
mirabegron; oral
+∞
9.6
9
*
C08CA13, ,
ATC
lercanidipine; oral
+∞
9.6
9
*
UDQ12, ,
ICD-O-3
+∞
9.6
9
*
WYA30, ,
ICD-O-3
+∞
9.6
9
*
C09CA06, ,
ATC
candesartan; oral
+∞
9.6
9
*
D07BB04, ,
ATC
hydrocortisone butyrate and antiseptics; topical
+∞
9.6
9
*
E119, ,
ICD-O-3
+∞
9.6
9
*
JN3AD, ,
ICD-O-3
+∞
9.6
9
*
Z961, ,
ICD-10 Finland
Presence of intraocular lens
+∞
9.6
9
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
9.6
9
*
R21, ,
ICD-O-3
+∞
9.6
9
*
N05CD07, ,
ATC
temazepam; oral
+∞
8.5
8
*
M01AX05, ,
ATC
glucosamine; oral
+∞
8.5
8
*
SPAT1360, ,
ICD-O-3
+∞
8.5
8
*
E000001, ,
ATC
+∞
8.5
8
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
8.5
8
*
UJF30, ,
ICD-O-3
+∞
8.5
8
*
N40, ,
ICD-O-3
+∞
8.5
8
*
NA1AD, ,
ICD-O-3
+∞
8.5
8
*
K219, ,
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
+∞
8.5
8
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
8.5
8
*
SPAT1217, ,
ICD-O-3
+∞
8.5
8
*
XF400, ,
ICD-O-3
+∞
8.5
8
*
SPAT1231, ,
ICD-O-3
+∞
8.5
8
*
H02, ,
ICD-O-3
+∞
8.5
8
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
8.5
8
*
C01DA08, ,
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
+∞
8.5
8
*
Z515, ,
ICD-10 Finland
Palliative care
+∞
8.5
8
*
R104, ,
ICD-O-3
+∞
8.5
8
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
8.5
8
*
D21, ,
ICD-O-3
+∞
8.5
8
*
E11, ,
ICD-O-3
+∞
8.5
8
*
SDA04, ,
ICD-O-3
+∞
8.5
8
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
8.5
8
*
R600, ,
ICD-O-3
+∞
8.5
8
*
W19, ,
ICD-10 Finland
Unspecified fall
+∞
8.5
8
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
8.5
8
*
C01DA14, ,
ATC
isosorbide mononitrate; oral
+∞
8.5
8
*
WX700, ,
ICD-O-3
+∞
8.5
8
*
VALMI, ,
ICD-O-3
+∞
8.5
8
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
8.5
8
*
L99, ,
ICD-O-3
+∞
8.5
8
*
M02AA10, ,
ATC
ketoprofen; topical
+∞
8.5
8
*
K0364, ,
ICD-O-3
+∞
8.5
8
*
NA1BG, ,
ICD-O-3
+∞
8.5
8
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
8.5
8
*
202, ,
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
8.5
8
*
M332, ,
ICD-10 Finland
Polymyositis
+∞
8.5
8
*
S97, ,
ICD-O-3
+∞
8.5
8
*
C03EA01, ,
ATC
hydrochlorothiazide and potassium-sparing agents; oral
+∞
8.5
8
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
8.5
8
*
A01, ,
ICD-O-3
+∞
8.5
8
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
8.5
8
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
8.5
8
*
TPH04, ,
ICD-O-3
+∞
8.5
8
*
L13, ,
ICD-O-3
+∞
7.4
7
*
R101, ,
ICD-10 Finland
Pain localized to upper abdomen
+∞
7.4
7
*
M751, ,
ICD-O-3
+∞
7.4
7
*
I639, ,
ICD-10 Finland
Cerebral infarction, unspecified
+∞
7.4
7
*
-44, ,
ICD-O-3
+∞
7.4
7
*
S01, ,
ICD-O-3
+∞
7.4
7
*
L16, ,
ICD-O-3
+∞
7.4
7
*
JKA21, ,
ICD-O-3
+∞
7.4
7
*
M609, ,
ICD-O-3
+∞
7.4
7
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
7.4
7
*
L04AX03, ,
ATC
methotrexate; systemic
+∞
7.4
7
*
M01AH01, ,
ATC
celecoxib; oral
+∞
7.4
7
*
NF1AA, ,
ICD-O-3
+∞
7.4
7
*
ND2AA, ,
ICD-O-3
+∞
7.4
7
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
7.4
7
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
7.4
7
*
E780, ,
ICD-O-3
+∞
7.4
7
*
NJ3CG, ,
ICD-O-3
+∞
7.4
7
*
SPAT1281, ,
ICD-O-3
+∞
7.4
7
*
H29, ,
ICD-O-3
+∞
7.4
7
*
206, ,
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
+∞
7.4
7
*
Z03, ,
ICD-O-3
+∞
7.4
7
*
Z2221, ,
ICD-O-3
+∞
7.4
7
*
R238, ,
ICD-O-3
+∞
7.4
7
*
J010, ,
ICD-O-3
+∞
7.4
7
*
B01AF02, ,
ATC
apixaban; oral
+∞
7.4
7
*
M791, ,
ICD-O-3
+∞
7.4
7
*
SPAT1083, ,
ICD-O-3
+∞
7.4
7
*
I480, ,
ICD-10 Finland
Paroxysmal atrial fibrillation
+∞
7.4
7
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
7.4
7
*
S060, ,
ICD-10 Finland
Concussion
+∞
7.4
7
*
Z027, ,
ICD-O-3
+∞
7.4
7
*
N06AA12, ,
ATC
doxepin; systemic
+∞
7.4
7
*
SDE02, ,
ICD-O-3
+∞
7.4
7
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
7.4
7
*
N17, ,
ICD-O-3
+∞
7.4
7
*
JN4BD, ,
ICD-O-3
+∞
7.4
7
*
PH2AE, ,
ICD-O-3
+∞
7.4
7
*
C03DA01, ,
ATC
spironolactone; oral
+∞
7.4
7
*
SDA01, ,
ICD-O-3
+∞
7.4
7
*
N40, ,
ICD-10 Finland
Hyperplasia of prostate
+∞
7.4
7
*
WX105, ,
ICD-O-3
+∞
7.4
7
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
7.4
7
*
SDE03, ,
ICD-O-3
+∞
7.4
7
*
SPAT1305, ,
ICD-O-3
+∞
7.4
7
*
I839, ,
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
+∞
7.4
7
*
SPAT1211, ,
ICD-O-3
+∞
7.4
7
*
UKC02, ,
ICD-O-3
+∞
7.4
7
*
XKD00, ,
ICD-O-3
+∞
7.4
7
*
ZXA00, ,
ICD-O-3
+∞
7.4
7
*
R02, ,
ICD-O-3
+∞
7.4
7
*
EBA05, ,
ICD-O-3
+∞
7.4
7
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
7.4
7
*
NA3AA, ,
ICD-O-3
+∞
7.4
7
*
D01AE16, ,
ATC
amorolfine; topical
+∞
7.4
7
*
N300, ,
ICD-10 Finland
Acute cystitis
+∞
7.4
7
*
R05, ,
ICD-10 Finland
Cough
+∞
7.4
7
*
R5140, ,
ICD-O-3
+∞
7.4
7
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
6.4
6
*
XG412, ,
ICD-O-3
+∞
6.4
6
*
C09DA06, ,
ATC
candesartan and diuretics; oral
+∞
6.4
6
*
XF404, ,
ICD-O-3
+∞
6.4
6
*
TQW40, ,
ICD-O-3
+∞
6.4
6
*
JN3BD, ,
ICD-O-3
+∞
6.4
6
*
Z000, ,
ICD-O-3
+∞
6.4
6
*
S04, ,
ICD-O-3
+∞
6.4
6
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
6.4
6
*
H531, ,
ICD-10 Finland
Subjective visual disturbances
+∞
6.4
6
*
45499, ,
ICD-8 Finland
Varicose veins of lower extremities, Other and unspecified, without ulcer
+∞
6.4
6
*
S010, ,
ICD-10 Finland
Open wound of scalp
+∞
6.4
6
*
NJ3BG, ,
ICD-O-3
+∞
6.4
6
*
H13, ,
ICD-O-3
+∞
6.4
6
*
J459, ,
ICD-O-3
+∞
6.4
6
*
M472, ,
ICD-10 Finland
Other spondylosis with radiculopathy
+∞
6.4
6
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
6.4
6
*
Z718, ,
ICD-O-3
+∞
6.4
6
*
K80, ,
ICD-O-3
+∞
6.4
6
*
K081, ,
ICD-O-3
+∞
6.4
6
*
M01AB55, ,
ATC
diclofenac, combinations; oral
+∞
6.4
6
*
TJD20, ,
ICD-O-3
+∞
6.4
6
*
ZY020, ,
ICD-O-3
+∞
6.4
6
*
81, ,
ICD-O-3
+∞
6.4
6
*
SPAT1100, ,
ICD-O-3
+∞
6.4
6
*
R06AX22, ,
ATC
ebastine; oral
+∞
6.4
6
*
R03DC03, ,
ATC
montelukast; oral
+∞
6.4
6
*
R01AD11, ,
ATC
triamcinolone; nasal
+∞
6.4
6
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
6.4
6
*
S21, ,
ICD-O-3
+∞
6.4
6
*
I693, ,
ICD-10 Finland
Sequelae of cerebral infarction
+∞
6.4
6
*
M17, ,
ICD-O-3
+∞
6.4
6
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
6.4
6
*
UGC12, ,
ICD-O-3
+∞
6.4
6
*
K800, ,
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
+∞
6.4
6
*
H01, ,
ICD-O-3
+∞
6.4
6
*
M54, ,
ICD-O-3
+∞
6.4
6
*
A46, ,
ICD-10 Finland
Erysipelas
+∞
6.4
6
*
H81, ,
ICD-O-3
+∞
6.4
6
*
Z094, ,
ICD-10 Finland
Follow-up examination after treatment of fracture
+∞
6.4
6
*
H0410, ,
ICD-10 Finland
Dry eye syndrome
+∞
6.4
6
*
NH3AA, ,
ICD-O-3
+∞
6.4
6
*
N201, ,
ICD-10 Finland
Calculus of ureter
+∞
6.4
6
*
N06AA09, ,
ATC
amitriptyline; systemic
+∞
6.4
6
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
6.4
6
*
SPAT1144, ,
ICD-O-3
+∞
6.4
6
*
J209, ,
ICD-10 Finland
Acute bronchitis, unspecified
+∞
6.4
6
*
K224, ,
ICD-10 Finland
Dyskinesia of oesophagus
+∞
6.4
6
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
6.4
6
*
JN4AD, ,
ICD-O-3
+∞
6.4
6
*
ZX120, ,
ICD-O-3
+∞
6.4
6
*
TNX33, ,
ICD-O-3
+∞
6.4
6
*
L309, ,
ICD-O-3
+∞
6.4
6
*
U04, ,
ICD-O-3
+∞
6.4
6
*
XG466, ,
ICD-O-3
+∞
6.4
6
*
G560, ,
ICD-10 Finland
Carpal tunnel syndrome
+∞
6.4
6
*
Z468, ,
ICD-10 Finland
Fitting and adjustment of other specified devices
+∞
6.4
6
*
C03AA03, ,
ATC
hydrochlorothiazide; oral
+∞
6.4
6
*
K802, ,
ICD-10 Finland
Calculus of gallbladder without cholecystitis
+∞
6.4
6
*
N394, ,
ICD-O-3
+∞
6.4
6
*
M511, ,
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
+∞
6.4
6
*
L01, ,
ICD-O-3
+∞
6.4
6
*
C08CA02, ,
ATC
felodipine; oral
+∞
6.4
6
*
D509, ,
ICD-10 Finland
Iron deficiency anaemia, unspecified
+∞
6.4
6
*
ZYC01, ,
ICD-O-3
+∞
6.4
6
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
6.4
6
*
FB1BD, ,
ICD-O-3
+∞
6.4
6
*
N04BC05, ,
ATC
pramipexole; oral
+∞
6.4
6
*
N06DX01, ,
ATC
memantine; oral
+∞
6.4
6
*
WX892, ,
ICD-O-3
+∞
6.4
6
*
N390, ,
ICD-O-3
+∞
6.4
6
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
6.4
6
*
A01AB09, ,
ATC
miconazole; local oral
+∞
6.4
6
*
N99, ,
ICD-O-3
+∞
6.4
6
*
J01MA01, ,
ATC
ofloxacin; systemic
+∞
6.4
6
*
-31, ,
ICD-O-3
+∞
6.4
6
*
E785, ,
ICD-10 Finland
Hyperlipidaemia, unspecified
+∞
6.4
6
*
G04BD08, ,
ATC
solifenacin; oral
+∞
6.4
6
*
JHB30, ,
ICD-O-3
+∞
6.4
6
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
19
7.68
5.42
1.7
1.6
—
—
—
0
0
12
21
6.93
5.09
1.7
1.9
—
—
—
0
0
20
80
3.31
4.11
2.3
1.8
—
—
—
0
0
25
120
2.93
3.72
2.7
1.7
1228.79
1296.03
nmol/l
0.12
15
85
7
10
7.79
3.47
2.0
1.5
—
—
—
0
0
38
237
2.81
3.33
9.0
8.2
1.22
1.22
mmol/l
0.04
32
198
36
222
2.69
3.17
9.5
7.1
1.21
1.21
mmol/l
0.09
31
191
29
164
2.56
3.01
3.9
3.5
1207.38
1792.86
ng/l
0.58
24
136
24
124
2.62
2.99
1.9
1.7
416.83
457.18
pmol/l
0.33
18
102
10
28
4.10
2.95
1.9
1.4
—
—
—
0
0
23
120
2.54
2.78
2.8
1.9
3.22
2.79
mg/l
0.31
18
105
36
232
2.50
2.75
16.8
14.1
1.28
1.26
inr
0.04
12
72
32
210
2.19
2.17
2.7
2.5
—
—
—
0
0
21
116
2.28
2.17
2.3
2.9
—
—
—
0
0
9
33
3.04
2.04
1.9
2.0
—
—
—
0
0
5
11
4.86
1.98
1.0
1.5
—
—
—
0
0
44
337
2.34
1.93
7.2
4.0
20.73
13.96
mm/h
1.45
37
297
22
138
1.97
1.57
3.0
3.1
0.52
0.18
e6/l
0.57
17
106
26
173
1.92
1.57
3.1
3.2
—
—
—
0
0
6
23
2.79
1.40
1.3
1.9
—
—
—
0
0
6
25
2.56
1.28
1.5
2.0
—
—
—
0
0
5
21
2.51
1.11
1.8
5.0
25.58
24.17
mmol/l
—
5
21
27
202
1.64
1.00
2.3
2.0
91.04
85.33
pmol/l
0.29
14
93
10
55
1.99
0.99
5.8
3.2
—
—
—
0
0
9
55
1.75
0.78
2.8
1.8
—
—
—
0
0
9
55
1.75
0.78
2.8
1.8
—
—
—
0
0
47
417
1.72
0.77
22.5
16.2
89.65
73.87
ml/min/173m2
3.07
39
326
51
467
1.87
0.70
28.6
19.3
68.78
83.66
umol/l
1.09
51
467
5
27
1.93
0.70
4.4
9.2
28.34
24.80
mmol/l
—
5
27
7
44
1.67
0.68
3.7
1.8
274.57
402.14
nmol/l
—
7
37
47
422
1.65
0.66
4.5
5.0
4.25
4.46
mmol/l
0.67
40
378
46
414
1.58
0.61
5.0
4.7
1.87
2.02
mu/l
0.50
41
357
45
404
1.54
0.59
4.6
4.4
1.38
1.23
mmol/l
0.94
38
351
46
420
1.49
0.50
4.8
4.9
1.39
1.49
mmol/l
0.82
40
367
7
48
1.52
0.49
2.1
5.9
6.80
5.77
kpa
—
7
48
27
228
1.35
0.46
3.5
4.1
0.00
0.00
estimate
—
8
45
47
434
1.47
0.44
6.0
5.2
6.03
6.01
mmol/l
0.03
37
380
5
31
1.67
0.44
2.6
1.5
—
—
—
0
0
26
220
1.33
0.43
4.0
2.9
—
—
—
0
0
33
369
0.75
0.42
33.8
19.1
17.05
15.19
%
0.79
33
363
0
15
0.00
0.42
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
27
231
1.32
0.41
4.1
4.1
0.00
0.00
estimate
—
9
42
47
441
1.37
0.32
5.1
5.6
2.51
2.56
mmol/l
0.14
41
385
26
227
1.27
0.32
5.3
5.7
0.00
0.00
estimate
—
9
42
15
174
0.81
0.21
6.8
5.7
2.05
2.32
ug/l
0.18
15
150
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
3.1
—
—
—
0
0
20
177
1.20
0.20
4.8
4.4
—
—
—
0
0
7
62
1.15
0.18
16.1
8.4
—
—
—
0
0
12
132
0.88
0.07
4.5
5.1
25.12
22.27
%
—
6
69
14
130
1.10
0.05
3.3
4.2
0.00
0.00
estimate
—
8
40
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
3.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
14.54
—
0
7
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
6
64
0.93
-0.00
5.5
8.7
103.67
103.42
mmol/l
—
6
64
Mortality – FinRegistry
↥Association
Association between endpoint G6_INFLAMYOP and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have G6_INFLAMYOP.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: G6_INFLAMYOP – Inflammatory myopathy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data